Tilray FY2025 EPS Reduced by Alliance Global Partners

Tilray Inc (NASDAQ:TLRY - Free Report) - Research analysts at Alliance Global Partners cut their FY2025 earnings estimates for shares of Tilray in a note issued to investors on Wednesday, April 9th. Alliance Global Partners analyst A. Grey now anticipates that the company will post earnings of ($1.02) per share for the year, down from their previous estimate of ($0.18). The consensus estimate for Tilray's current full-year earnings is ($0.20) per share.

Several other equities analysts have also commented on TLRY. Piper Sandler dropped their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 9th. Canaccord Genuity Group increased their target price on shares of Tilray from $2.00 to $3.00 and gave the company a "buy" rating in a research report on Monday, January 13th.

Tilray Price Performance

Shares of NASDAQ TLRY opened at $0.49 on Monday. The stock's 50-day simple moving average is $0.71 and its 200-day simple moving average is $1.16. The firm has a market capitalization of $456.45 million, a PE ratio of -1.62 and a beta of 1.88. Tilray has a fifty-two week low of $0.44 and a fifty-two week high of $2.52. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54.

Remove Ads

Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). The business had revenue of $185.78 million during the quarter, compared to analyst estimates of $213.38 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%.

Institutional Investors Weigh In On Tilray

Several large investors have recently modified their holdings of the company. California State Teachers Retirement System raised its position in Tilray by 8.0% in the 4th quarter. California State Teachers Retirement System now owns 778,513 shares of the company's stock valued at $1,035,000 after purchasing an additional 57,544 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Tilray by 317.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 166,326 shares of the company's stock worth $221,000 after buying an additional 126,507 shares during the period. Toronto Dominion Bank grew its holdings in shares of Tilray by 53.0% during the fourth quarter. Toronto Dominion Bank now owns 197,207 shares of the company's stock worth $260,000 after buying an additional 68,284 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Tilray by 17.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,964,380 shares of the company's stock valued at $2,613,000 after acquiring an additional 286,481 shares during the period. Finally, Two Sigma Advisers LP raised its stake in Tilray by 81.7% during the 4th quarter. Two Sigma Advisers LP now owns 164,800 shares of the company's stock valued at $219,000 after acquiring an additional 74,100 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.